Wedmont Private Capital’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.01M Sell
4,299
-354
-8% -$73.6K 0.03% 345
2026
Q1
$1M Buy
4,653
+321
+7% +$69.1K 0.03% 316
2025
Q4
$898K Buy
4,332
+115
+3% +$21.6K 0.03% 315
2025
Q3
$661K Buy
4,217
+102
+2% +$15.8K 0.02% 374
2025
Q2
$676K Buy
4,115
+133
+3% +$19.7K 0.03% 356
2025
Q1
$525K Buy
3,982
+154
+4% +$19.6K 0.03% 372
2024
Q4
$465K Buy
3,828
+131
+4% +$15.3K 0.02% 403
2024
Q3
$413K Sell
3,697
-109
-3% -$11.4K 0.02% 417
2024
Q2
$358K Buy
3,806
+339
+10% +$34.5K 0.02% 438
2024
Q1
$375K Buy
3,467
+194
+6% +$20.9K 0.03% 391
2023
Q4
$344K Buy
3,273
+354
+12% +$35.1K 0.03% 389
2023
Q3
$265K Buy
2,919
+517
+22% +$46.7K 0.03% 410
2023
Q2
$224K Buy
+2,402
New +$203K 0.02% 445

Other funds holding CAH

Wedmont Private Capital's CAH Position: Q2 2026 in Review

Wedmont Private Capital reduced its Cardinal Health (CAH) stake by 7.6% in Q2 2026, selling an estimated $73.6K and leaving 4,299 shares worth $1.01M. The position accounts for 0.03% of the portfolio, ranked #345.

Wedmont Private Capital first reported a position in CAH in Q2 2023 and has held it in 13 quarters since. 449 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Wedmont Private Capital held 4,299 shares of Cardinal Health worth $1.01M as of Q2 2026.
  • Wedmont Private Capital sold 354 Cardinal Health shares in Q2 2026, an estimated $73.6K.
  • Cardinal Health made up 0.03% of Wedmont Private Capital's portfolio in Q2 2026, its #345 holding.
  • Wedmont Private Capital first reported a position in Cardinal Health in Q2 2023 and has held it in 13 quarters since.
  • 449 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Wedmont Private Capital's 13F filing for Q2 2026, filed 13 Jul 2026.